Pregled bibliografske jedinice broj: 229055
CYTOKINE PROFILE AND ITS INFLUENCE TO ACR INDEX IN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH INFLIXIMAB
CYTOKINE PROFILE AND ITS INFLUENCE TO ACR INDEX IN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH INFLIXIMAB // Ann Rheum Dis 2005 ; 64(Suppl III):451
Beč, Austrija: BMJ, 2005. (poster, međunarodna recenzija, sažetak, znanstveni)
CROSBI ID: 229055 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
CYTOKINE PROFILE AND ITS INFLUENCE TO ACR INDEX IN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH INFLIXIMAB
Autori
Novak, Srđan ; Anić, Branimir ; Čikeš, Nada ; Bosnic, Dubravka ; Sentić, Mirna ; Budiselic, R ;
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni
Izvornik
Ann Rheum Dis 2005 ; 64(Suppl III):451
/ - : BMJ, 2005
Skup
Annual European Congress of Rheumatology, EULAR 2005
Mjesto i datum
Beč, Austrija, 08.06.2005. - 11.06.2005
Vrsta sudjelovanja
Poster
Vrsta recenzije
Međunarodna recenzija
Ključne riječi
infliximab; cytokines; disease activity
Sažetak
Background: During infliximab treatment in rheumatoid arthritis (RA) patients, inhibition of TNF alfa and consequently the changes in levels of other cytokines occurs. Objectives: To evaluate changes of IL-6, sTNFR and IL-10 during infliximab and methotrexate (MTX)treatment in the period of 62 weeks and correlate their values with ACR index. Methods: 24 patients with active RA despite therapy with MTX were treated with infliximab in dosage of 3 mg/kg in weeks 0, 2, 6 and then every 8 weeks until week 54. All patients were on MTX. ACR index was calculated in week 0, 6, 30 and 62. ESR, CRP, IL-6, sTNFR and IL-10 were measured in weeks 2, 4, 6, 14, 30, 54 and 62. Results: Already after the first application of infliximab levels of CRP (p=0.0004), IL-6 (p=0.000002) and sTNFR (p=0.00003) significantly reduced, and statistically significant difference was maintained until week 62. There were no statistically significant changes in values of IL-10. Comparing values of IL-6 with ACR index, non-responders were found to have levels of IL-6 significantly higher(p=0.037) than responders. However, values of sTNFR in comparison with ACR index have not shown statistically significant changes (p=0.12). Conclusion: Treatment with infliximab leads to reduction of IL-6 and sTNFR after the first application of the drug. Values of IL-6 correlate well with ACR index while values of sTNFR do not differ in responders and non-responders to infliximab.
Izvorni jezik
Engleski
Znanstvena područja
Temeljne medicinske znanosti, Kliničke medicinske znanosti
POVEZANOST RADA
Projekti:
0108190
Ustanove:
Medicinski fakultet, Zagreb,
Klinički bolnički centar Zagreb